ReP USP - Resultado da busca

Filtros : "Nikiphorou, Elena" Limpar

Filtros

Countries of institutions of collaboration
- austrália (2)
- bangladesh (2)
- grã-bretanha (reino unido, uk) (2)
- índia (2)
- polônia (1)

Artigo de periodico
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2023)
Dey, Mrinalini ; Naveen, R ; Nikiphorou, Elena ; Sen, Parikshit ; Saha, Sreoshy ; Lilleker, James B ; Agarwal, Vishwesh ; Kardes, Sinan ; Day, Jessica ; Milchert, Marcin ; Shinjo, Samuel Katsuyuki
Source: Rheumatology. Unidade: FM
Subjects: COVID-19, DOENÇAS AUTOIMUNES, VACINAÇÃO, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEY, Mrinalini et al. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology, v. 62, n. 5, p. E147-E152, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53815. Acesso em: 06 jun. 2024.
APA
Dey, M., Naveen, R., Nikiphorou, E., Sen, P., Saha, S., Lilleker, J. B., et al. (2023). Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology, 62( 5), E147-E152. doi:10.1093/rheumatology/keac603
NLM
Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, Kardes S, Day J, Milchert M, Shinjo SK. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 5): E147-E152.[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53815
Vancouver
Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, Kardes S, Day J, Milchert M, Shinjo SK. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 5): E147-E152.[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53815
Artigo de periodico
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023)
Doskaliuk, Bohdana; Ravichandran, Naveen ; Sen, Parikshit ; Day, Jessica ; Joshi, Mrudula; Nune, Arvind; Nikiphorou, Elena ; Saha, Sreoshy ; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki
Source: Rheumatology international. Unidade: FM
Subjects: VACINAÇÃO, COVID-19, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOSKALIUK, Bohdana et al. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, v. 43, n. 9, p. 1651-1664, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55968. Acesso em: 06 jun. 2024.
APA
Doskaliuk, B., Ravichandran, N., Sen, P., Day, J., Joshi, M., Nune, A., et al. (2023). Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, 43( 9), 1651-1664. doi:10.1007/s00296-023-05345-y
NLM
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
Vancouver
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024